Gene: ANKRD29
Official Full Name: ankyrin repeat domain 29provided by HGNC
Gene Summary: Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23736 | ANKRD29 Knockout cell line (HeLa) | Human | ANKRD29 | 1:3~1:6 | Negative | Online Inquiry |
KO23737 | ANKRD29 Knockout cell line (HCT 116) | Human | ANKRD29 | 1:2~1:4 | Negative | Online Inquiry |
KO23738 | ANKRD29 Knockout cell line (HEK293) | Human | ANKRD29 | 1:3~1:6 | Negative | Online Inquiry |
KO23739 | ANKRD29 Knockout cell line (A549) | Human | ANKRD29 | 1:3~1:4 | Negative | Online Inquiry |
ANKRD29 Gene Knockout Cell Lines are meticulously engineered cellular models designed to facilitate the study of the ANKRD29 gene's role in various biological processes and diseases. Gene knockout technology involves the targeted disruption of a specific gene, thereby enabling researchers to observe the resultant phenotypic changes and gain insights into gene function. These cell lines serve as powerful tools for understanding gene knockout effects on cellular signaling pathways, gene expression, and overall cellular phenotype.
The primary mechanism of the ANKRD29 knockout system relies on CRISPR-Cas9 or similar genome-editing techniques that introduce precise mutations in the gene of interest. Upon disruption of the ANKRD29 gene, researchers can investigate its involvement in cellular mechanisms such as stress response, differentiation, and proliferation. This is particularly crucial given the gene's potential implications in oncogenesis and metabolic disorders.
In the realm of scientific research and clinical applications, ANKRD29 Gene Knockout Cell Lines hold immense value. They can be employed in basic research to delineate cellular pathways influenced by ANKRD29, as well as in drug discovery, where understanding gene function is pivotal for developing targeted therapies. These cell lines can also serve as control models in experiments, further broadening their utility in translational medicine.
What sets our ANKRD29 Gene Knockout Cell Lines apart is the unmatched specificity and efficiency of gene editing, ensuring high fidelity in knockout performance. Additionally, these cell lines are developed under stringent quality controls, offering researchers reliable, reproducible results.
For researchers and clinicians focused on unveiling the intricacies of gene function in health and disease, our ANKRD29 knockouts provide an invaluable research tool that accelerates discovery. Our company, with years of expertise in genetic manipulation and cell line development, is committed to offering high-quality biological products that empower scientific advancement.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.